Online citations, reference lists, and bibliographies.
← Back to Search

Identification Of Potential Cross-protective Epitope Between A New Type Of Coronavirus (2019-nCoV) And Severe Acute Respiratory Syndrome Virus

Tianyi Qiu, Tiantian Mao, Yuan Wang, Mengdi Zhou, Jingxuan Qiu, Jianwei Wang, Jianqing Xu, Zhiwei Cao
Published 2020 · Medicine, Biology

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
This paper references
Mapping Epitope Structure and Activity: From One-Dimensional Prediction to Four-Dimensional Description of Antigenic Specificity
Van Regenmortel MHV (1996)
10.1006/METH.1996.0054
Mapping Epitope Structure and Activity: From One-Dimensional Prediction to Four-Dimensional Description of Antigenic Specificity
M. V. Regenmortel (1996)
WHO (2003)
10.1074/jbc.M600697200
Structure of Severe Acute Respiratory Syndrome Coronavirus Receptor-binding Domain Complexed with Neutralizing Antibody*
P. Prabakaran (2006)
10.1074/jbc.M603275200
Structural Basis of Neutralization by a Human Anti-severe Acute Respiratory Syndrome Spike Protein Antibody, 80R*
W. C. Hwang (2006)
Structural basis of neutral
L. ewski (2006)
10.1371/journal.ppat.1002859
Structural Bases of Coronavirus Attachment to Host Aminopeptidase N and Its Inhibition by Neutralizing Antibodies
J. Reguera (2012)
10.3923/AJAVA.2014.164.176
Coronavirus Infection in Equines: A Review
K. Dhama (2014)
10.1038/nature17200
Pre-fusion structure of a human coronavirus spike protein
R. Kirchdoerfer (2016)
10.2807/1560-7917.ES.2017.22.13.30494
GISAID: Global initiative on sharing all influenza data – from vision to reality
Y. Shu (2017)
GISAID: Global initiat
Y. 1.2022.914952. Shu (2017)
10.1038/s41467-018-04171-2
CE-BLAST makes it possible to compute antigenic similarity for newly emerging pathogens
Tianyi Qiu (2018)
WHO (2018)
10.1186/s12985-019-1182-0
Coronavirus envelope protein: current knowledge
D. Schoeman (2019)
Coronavirus env
D. Schoeman (2019)
10.1007/s11427-020-1637-5
Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission
X. Xu (2020)
10.1101/2020.01.22.914952
Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin
P. Zhou (2020)
10.1038/s41586-020-2012-7
A pneumonia outbreak associated with a new coronavirus of probable bat origin
P. Zhou (2020)
10.1038/s41423-020-0385-z
Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV
Ming Zheng (2020)
Zhang (2020)
Evolution of the nov
W. Zhong (2020)
Initial Genome Release of Novel Coronavirus
Y Z Zhang (2020)
Discovery of a novel coronavirus
G. Xiao (2020)
WHO (2020)
Initial Genome Release of Novel Coronavirus. http://virological. org/t/initial-genome-release-of-novel-coronavirus/319?from1⁄4groupmessage
Y. Z. Zhang (2020)
WHO MERS-CoV Global Summary and Assessment of Risk
W H O Who
Shanghai 10 th People's Hospital, School of Life Sciences and Technology
Department
Summary of probable SARS cases with onset of illness from 1
W H O Who
WHO MERS-CoV Global Summary and Assessment of Risk
Summary of Probable SARS Cases with Onset of Illness from 1
*Correspondence should be addressed to J.X. (email: xujianqing@shphc.org.cn) or
Chinese Academy of Medical Science & Peking Union Medical College, Beijing, 100730, China Jianqing Xu ** Shanghai Public Health Clinical Center
1 TiantianMao
Pneumonia of Unknown Cause in China
Who
Chinese Academy of Medical Science & Peking Union Medical College
Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003
W. H. O. WHO



This paper is referenced by
10.3390/v13081667
Peptide Platform as a Powerful Tool in the Fight against COVID-19
M. Murdocca (2021)
10.1177/11786361211002481
Corona Viruses: A Review on SARS, MERS and COVID-19
Nihala Naseefa Chathappady House (2021)
10.1111/cei.13517
Vaccines for COVID‐19
J. Tregoning (2020)
10.1016/j.tmaid.2020.101647
Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence
Yujuan Cao (2020)
10.3389/fmicb.2020.01858
CoronaVR: A Computational Resource and Analysis of Epitopes and Therapeutics for Severe Acute Respiratory Syndrome Coronavirus-2
A. Gupta (2020)
10.1007/s12038-020-00114-6
COVID-19: Advances in diagnostic tools, treatment strategies, and vaccine development
M. Sreepadmanabh (2020)
10.3233/XST-200687
Clinical and radiological features of novel coronavirus pneumonia
Qiuting Zheng (2020)
10.1111/sji.12895
SARS‐CoV‐2 infection‐induced immune responses: friends or foes?
Keying Li (2020)
10.1101/2020.06.16.154591
Antigenic evolution on global scale reveals potential natural selection of SARS-CoV-2 by pre-existing cross-reactive T cell immunity
C. Zhang (2020)
10.1371/journal.ppat.1008762
COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2
A. Mittal (2020)
10.12688/f1000research.23458.2
Expected immune recognition of COVID-19 virus by memory from earlier infections with common coronaviruses in a large part of the world population
J. M. Dijkstra (2020)
10.1038/s41423-020-0385-z
Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV
Ming Zheng (2020)
10.1101/2020.05.21.108563
SARS-CoV-2 mutations and where to find them: An in silico perspective of structural changes and antigenicity of the Spike protein
R. Gonçalves (2020)
10.1007/s12250-020-00297-0
COVID-19: Antiviral Agents, Antibody Development and Traditional Chinese Medicine
Wenyi Guan (2020)
10.7150/ijbs.48812
Update of the current knowledge on genetics, evolution, immunopathogenesis, and transmission for coronavirus disease 19 (COVID-19)
K. Tizaoui (2020)
10.3389/fmed.2020.558835
Covid-19 Pandemic: Maximizing Future Vaccination Treatments Considering Aging and Frailty
S. Palermo (2020)
10.12688/f1000research.23458.1
Expected immune recognition of COVID-19 virus by memory from earlier infections with common coronaviruses in a large part of the world population.
J. M. Dijkstra (2020)
10.1080/07391102.2020.1844052
SARS-CoV-2 mutations and where to find them: an in silico perspective of structural changes and antigenicity of the spike protein.
R. Gonçalves (2020)
10.1101/2020.02.18.20024513
Estimating the cure rate and case fatality rate of the ongoing epidemic COVID-19
Y. Diao (2020)
Semantic Scholar Logo Some data provided by SemanticScholar